A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 18, Issue 8, 2005, Pages 749-754

  Crino A ^a   Schiaffini, R ^a   Ciampalini, P ^a   Suraci, M C ^a   Manfrini, S ^a   Visalli, N ^a   Matteoli, M C ^a   Patera, P ^a   Buzzetti, R ^a   Guglielmi, C ^a   Spera, S ^a   Costanza, F ^a   Fioriti, E ^a   Pitocco, D ^a   Pozzilli, Paolo ^a   Corbi, S ^a   Cervoni, M ^a   Manca Bitti, M L ^a   Bizzarri, C ^a   Lauria Pantano, A ^a   Cipolloni, L ^a   Coppolino, G ^a   Valente, L ^a   Beretta Anguissola, G ^a   Montemari, A L ^a   Cappa, M ^a   Di Stasio, E ^a   Nistico L ^a   Petrone, A ^a   Cavallo, M G ^a   Ghirlanda, G ^a   more..

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

C peptide; Intensive insulin therapy; Nicotinamide; Type 1 diabetes mellitus

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; INSULIN; ISOPHANE INSULIN; NICOTINAMIDE;

ADD ON THERAPY; ADOLESCENT; ADULT; ARTICLE; DRUG DOSE REGIMEN; FOLLOW UP; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LONG TERM CARE; MAJOR CLINICAL STUDY; PANCREAS ISLET BETA CELL; PROTEIN SECRETION; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; C-PEPTIDE; CHILD; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; NIACINAMIDE; RETROSPECTIVE STUDIES;

EID: 24944438390     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 997-986.
2. Pozzilli P, Visalli N, Boccuni ML, Baroni MG, Buzzetti R, Fioriti E, Signore A, Cavallo MG, Andreani D, Lucentini L, Crinò A, Cicconetti CA, Teodonio C, Amoretti R, Pisano L, Pennafina MG, Santopadre G, Marozzi G, Multari G, Campea L, Suppa MA, De Mattia GC, Cassone Faldetta M, Marietti G, Perrone F, Greco AV, Ghirlanda G. Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin dependent diabetes. Diabet Med 1994; 11: 98-104.
3. Pozzilli P, on behalf of the IMDIAB Study Group. Combination of nicotinamide and steroid versus nicotinamide in recent onset insulin-dependent diabetes (The IMDIAB II Study). Diabetes Care 1994; 17: 897-900.
4. Pozzilli P, Visalli N, Signore A, Baroni MG, Buzzetti R, Cavallo MG, Boccuni ML, Valente, Mesturino C, Andreani D, Lucentini L, Matteoli MC, Crinò A, Cicconetti CA, Teodonio C, Paci F, Amoretti R, Pisano L, Pennafina MG, Santopadre G, Marozzi G, Multari G, Suppa M, De Mattia GC, Cassone Faldetta M, Marietti G, Perrone F, Greco A, Ghirlanda G. Double blind trial of nicotinamide in recent onset insulin dependent diabetes mellitus. Diabetologia 1995; 38: 848-852.
5. Pozzilli P, Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, the IMDIAB Group. Vitamin E and nicotinamide have similar effects in maintaining residual beta-cell function in recent onset insulin-dependent diabetes (the IMDIAB IV Study). Eur J Endocrinol 1997; 137: 234-239.
6. Pozzilli P, the IMDIAB Group. BCG vaccine in recent-onset IDDM: a bitter ending. Lancet 1997; 349: 1520-1521.
7. Visalli N, Cavallo MG, Signore A, Baroni MG, Pozzilli P, on behalf of the IMDIAB Group. A multicenter randomised trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (The IMDIAB VI). Diabetes Metab Rev 1999; 15: 181-185.
8. Paolo V, Saibene A, Pontiroli AE. Nicotinamide improves insulin secretion and metabolic control in lean type 2 diabetic patients with secondary failure to sulphonylureas. Acta Diabetol 1998; 35: 61-64.
9. Lampeter EF, Klinghammer A, Scherbaum WA, Heinze E, Haastert B, Giani G, Kolb H. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes 1998; 47: 980-984.
10. Pozzilli P, Browne PD, Kolb H, the Nicotinamide Trialists. Meta-analysis of nicotinamide treatment in patients with recent onset insulin dependent diabetes. Diabetes Care 1996; 19: 1357-1363.
11. Klein R, Klein BEK, Moss SC. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: the relationship of C-peptide to the incidence and progression of diabetic retinopathy. Diabetes 1995; 44: 796-801.
12. Gale EA, Bingley PJ, Emmett CL, Collier T, European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 2004; 363: 925-931.